L-arginine deficiency after liver transplantation as an effect of arginase efflux from the graft: Influence on nitric oxide metabolism

Transplantation

Volumn 57, Issue 5, 1994, Pages 665-669

  Roth, Erich ^a   Steininger, Rudolf ^a   Winkler, Susanne ^a   Längle, Friedrich ^a   Grünberger, Thomas ^a   Függer, Reinhold ^a   Mühlbacher, Ferdinand ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGINASE; ARGININE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; NITRATE; NITRITE; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID DEFICIENCY; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METABOLISM; LIVER TRANSPLANTATION; MALE; ORGAN PERFUSION; PRIORITY JOURNAL; REPERFUSION; UREA CYCLE; VASCULAR ENDOTHELIUM;

ADULT; ARGINASE; ARGININE; FEMALE; FEMORAL VEIN; HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGE; NITRIC OXIDE; RADIAL ARTERY;

EID: 0028176661     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199403150-00006     Document Type: Article

References (36)

1. Svensson KL, Persson H, Henriksson BA, et al. Whole body gas exchange: amino acid and lactate clearance as indicators of initial and early allograft viability in liver transplantation. Surgery 1989; 105: 472.
2. Kamiike W, Burdelski M, Steinhoff G, Ringe B, Lauchart W, Pichlmayr R. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 1988; 45: 138.
3. Jenkins RL, Bosari S, Khettry U, Clowes GHA, Pearl RH, Trey C. Survival from hepatic transplantation. Relationship of protein synthesis to histological abnormalities in patient selection and postoperative management. Ann Surg 1986; 204: 364.
4. Fath JJ, Ascher NL, Konstantinides FN, et al. Metabolism dur ing hepatic transplantation: indicators of allograft function. Surgery 1984; 96: 664.
5. Taki Y, Gubematis G, Yamaoka Y, et al. Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation 1990; 49: 535.
6. Shimada M, Yanaga K, Kishikawa K, et al. Prediction of hepatic graft viability before reperfusion: an analysis of effluent from porcine allografts. Transplant Int 1993; 6: 4.
7. Montanari A, Simoni I, Vallisa D, et al. Free amino acids in plasma and skeletal muscle of patients with liver cirrhosis. Hepatology 1988; 8: 1034.
8. Roth E, Funovics J, Kamer J, et al. Muscle amino acid levels in patients with liver diseases. In: Kleinberger G, Ferenci P, Riederer P, Thaler H, eds. Advances in hepatic encephalopathy and urea cycle disease. Basel, Switzerland: S. Karger 1984: 527.
9. Roth E, Muehlbacher F, Karner J, Steininger R, Schemper M, Funovics J. Liver amino acids in sepsis. Surgery 1985; 97: 436.
10. Fahey JL. Toxicity and blood ammonia rise resulting from in travenous amino acid administration in man: the protective effect of L-arginine. J Clin Invest 1957; 36: 1647.
11. Barbul A, Rhonda SF, Shimazu S, et al. Intravenous hyperali mentation with high L-arginine levels improves wound healing and immune function. J Surg Res 1985; 38: 328.
12. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of L-arginine in the surgical patient. Ann Surg 1988; 208: 512.
13. Albina JE, Mills CD, Barbul A, et al. L-Arginine metabolism in wounds. Am J Physiol 1988; 254: E459.
14. Rogers QRR, Visek WJ. Metabolic role of urea cycle Intermedi ates: nutritional and clinical aspects. J Nutr 1985; 115: 505.
15. Kline JJ, Hug G, Schubert WK, et al. Arginine deficiency syn drome. Am J Dis Child 1981; 135: 437.
16. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109.
17. Furchgott RF. The role of endothelium in the response of vascu lar smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984; 24: 175.
18. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent in hibition of platelet aggregation. Br J Pharmacol 1986; 88: 411.
19. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87.
20. Langrehr JM, Hoffman RA, Billiar TR, Lee KKW, Schraut WH, Simmons RL. Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. Surgery 1991; 110: 335.
21. Visser JJ, van Kam GJ, Donker AJM. Urinary nitrite/nitrate ratio: marker for renal allograft rejection? Clin Chem 1991; 37: 1303.
22. Turnell DC, Cooper JDH. Rapid assay for amino acids in serum or urine by pre-column derivatization and reverse-phase liquid chromatography. Clin Chem 1991; 28: 52.
23. Kaneda N, Sato M, Yagi K. Analysis of dansyl amino acids by reverse-phase high-performance liquid chromatography. J Chromatogr 1982; 127: 410.
24. Bastone A, Diomede L, Parini R, Carnevale F, Salmona M. De termination of argininosuccinate lyase and arginase activities with an amino acid analyzer. Anal Biochem 1990; 191: 384.
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131.
26. Schmidt HHHW, Warner TD, Nakane M, Förstermann U. Regu lation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol 1992; 41: 615.
27. Barbul A. L-Arginine: biochemistry, physiology, and therapeutic implications. J Parenter Enteral Nutr 1986; 10: 227.
28. Curran RD, Biliar TR, Stuehr DJ, Hofmann K, Simmons RL. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989; 170: 1769.
29. Biliar TR, Curran RD, Stuehr DJ, Ferrari FK, Simmons RL. An L-arginine dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989; 169: 1467.
30. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide acti vates guanylate cyclase and increased guanosine 1:2 cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sei USA 1977; 74: 3203.
31. Mayer B, Schmidt K, Humbert R, Bohme E. Biosynthesis of endothelium-derived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cells Ca2+ dependently converts L-argi-nine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Commun 1989; 164: 687.
32. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun 1989; 164: 714.
33. Beasley D, Schwartz JH, Brenner BM. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophos-hate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87: 602.
34. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997.
35. Gabriel A, Müller C, Tüchy G, Hackl W, Zimpfer M. Reperfusion during orthotopic liver transplantation: analysis of right ventricular dynamics. Transplant Proc 1993; 25: 1811.
36. Zadrobilek E, Mauritz W, Feil W, Wenzl E, Sporn P. Hämodynamische und metabolische Änderungen während orthotoper Lebertransplantation. Anaesthesist 1988; 37: 672.